FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998774002> ?p ?o ?g. }

• W1998774002 endingPage "277" @default.
• W1998774002 startingPage "271" @default.
• W1998774002 abstract "The in vitro stability of monoclonal antibodies used for age-related macular degeneration, ranibizumab and bevacizumab, was investigated. The aggregation profile of the antibodies was compared, alone and after association with dexamethasone sodium phosphate or triamcinolone acetonide. Commercial formulations of ranibizumab and bevacizumab were dialysed into three different buffers. After dialysis, samples were stored at 4°C, 25°C and 40°C during 35 days, alone and in combination with dexamethasone sodium phosphate, triamcinolone acetonide phosphate solution or triamcinolone acetonide suspension. Combined formulations based on both commercial formulations were investigated as well. The aggregation state of the antibodies was measured by multi-angle light scattering (MALS) after separation by asymmetrical flow field-flow fractionation (AFFF) or size-exclusion chromatography (SEC). Ranibizumab results to be more stable than bevacizumab, alone and in combination with dexamethasone sodium phosphate or triamcinolone acetonide. Elevation in concentration, pH and temperature causes a decrease in stability of both antibodies. The association of triamcinolone acetonide phosphate solution with either ranibizumab or bevacizumab is observed to be the least stable combination of all samples tested. Dexamethasone sodium phosphate was shown to have a stabilizing effect on bevacizumab, although this is not the case for its combination with the commercial formulation Avastin®. The results demonstrate that the in vitro association of either ranibizumab or bevacizumab with dexamethasone sodium phosphate or triamcinolone acetonide suspension does not decrease the stability of these antibodies. Although ranibizumab is more stable than bevacizumab in vitro, further research has to point out how this affects their mechanism of action in vivo." @default.
• W1998774002 created "2016-06-24" @default.
• W1998774002 creator A5011737122 @default.
• W1998774002 creator A5013683035 @default.
• W1998774002 creator A5037720436 @default.
• W1998774002 creator A5073897456 @default.
• W1998774002 creator A5084054147 @default.
• W1998774002 date "2011-06-01" @default.
• W1998774002 modified "2023-09-24" @default.
• W1998774002 title "Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: An in vitro stability assessment" @default.
• W1998774002 cites W1581858536 @default.
• W1998774002 cites W1967800067 @default.
• W1998774002 cites W1970825242 @default.
• W1998774002 cites W1977305573 @default.
• W1998774002 cites W1981891070 @default.
• W1998774002 cites W1991120368 @default.
• W1998774002 cites W1994809597 @default.
• W1998774002 cites W1997612534 @default.
• W1998774002 cites W2007337013 @default.
• W1998774002 cites W2012422371 @default.
• W1998774002 cites W2047301512 @default.
• W1998774002 cites W2048049691 @default.
• W1998774002 cites W2048427986 @default.
• W1998774002 cites W2053537643 @default.
• W1998774002 cites W2069838435 @default.
• W1998774002 cites W2073948759 @default.
• W1998774002 cites W2079843091 @default.
• W1998774002 cites W2093269333 @default.
• W1998774002 cites W2093861673 @default.
• W1998774002 cites W2104232975 @default.
• W1998774002 cites W2111877521 @default.
• W1998774002 cites W280478335 @default.
• W1998774002 cites W2915852396 @default.
• W1998774002 doi "https://doi.org/10.1016/j.ejpb.2010.12.018" @default.
• W1998774002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21172437" @default.
• W1998774002 hasPublicationYear "2011" @default.
• W1998774002 type Work @default.
• W1998774002 sameAs 1998774002 @default.
• W1998774002 citedByCount "20" @default.
• W1998774002 countsByYear W19987740022013 @default.
• W1998774002 countsByYear W19987740022014 @default.
• W1998774002 countsByYear W19987740022015 @default.
• W1998774002 countsByYear W19987740022016 @default.
• W1998774002 countsByYear W19987740022017 @default.
• W1998774002 countsByYear W19987740022018 @default.
• W1998774002 countsByYear W19987740022019 @default.
• W1998774002 countsByYear W19987740022020 @default.
• W1998774002 countsByYear W19987740022021 @default.
• W1998774002 countsByYear W19987740022022 @default.
• W1998774002 crossrefType "journal-article" @default.
• W1998774002 hasAuthorship W1998774002A5011737122 @default.
• W1998774002 hasAuthorship W1998774002A5013683035 @default.
• W1998774002 hasAuthorship W1998774002A5037720436 @default.
• W1998774002 hasAuthorship W1998774002A5073897456 @default.
• W1998774002 hasAuthorship W1998774002A5084054147 @default.
• W1998774002 hasConcept C118487528 @default.
• W1998774002 hasConcept C126322002 @default.
• W1998774002 hasConcept C185592680 @default.
• W1998774002 hasConcept C2776694085 @default.
• W1998774002 hasConcept C2776804153 @default.
• W1998774002 hasConcept C2777802072 @default.
• W1998774002 hasConcept C2778903070 @default.
• W1998774002 hasConcept C2780401358 @default.
• W1998774002 hasConcept C2781100027 @default.
• W1998774002 hasConcept C2910181907 @default.
• W1998774002 hasConcept C43617362 @default.
• W1998774002 hasConcept C71924100 @default.
• W1998774002 hasConcept C98274493 @default.
• W1998774002 hasConceptScore W1998774002C118487528 @default.
• W1998774002 hasConceptScore W1998774002C126322002 @default.
• W1998774002 hasConceptScore W1998774002C185592680 @default.
• W1998774002 hasConceptScore W1998774002C2776694085 @default.
• W1998774002 hasConceptScore W1998774002C2776804153 @default.
• W1998774002 hasConceptScore W1998774002C2777802072 @default.
• W1998774002 hasConceptScore W1998774002C2778903070 @default.
• W1998774002 hasConceptScore W1998774002C2780401358 @default.
• W1998774002 hasConceptScore W1998774002C2781100027 @default.
• W1998774002 hasConceptScore W1998774002C2910181907 @default.
• W1998774002 hasConceptScore W1998774002C43617362 @default.
• W1998774002 hasConceptScore W1998774002C71924100 @default.
• W1998774002 hasConceptScore W1998774002C98274493 @default.
• W1998774002 hasIssue "2" @default.
• W1998774002 hasLocation W19987740021 @default.
• W1998774002 hasLocation W19987740022 @default.
• W1998774002 hasOpenAccess W1998774002 @default.
• W1998774002 hasPrimaryLocation W19987740021 @default.
• W1998774002 hasRelatedWork W1668980245 @default.
• W1998774002 hasRelatedWork W1995044506 @default.
• W1998774002 hasRelatedWork W2004778795 @default.
• W1998774002 hasRelatedWork W2014975030 @default.
• W1998774002 hasRelatedWork W2039214400 @default.
• W1998774002 hasRelatedWork W2042956061 @default.
• W1998774002 hasRelatedWork W2046854454 @default.
• W1998774002 hasRelatedWork W2067579161 @default.
• W1998774002 hasRelatedWork W2336111296 @default.
• W1998774002 hasRelatedWork W3063310417 @default.
• W1998774002 hasVolume "78" @default.
• W1998774002 isParatext "false" @default.

• next